[1] |
Writing committee of the report on cardiovascular health and diseases in china. Report on cardiovascular health and diseases in China 2021: an updated summary[J]. Biomed Environ Sci, 2022, 35(7): 573-603.
|
[2] |
王青青, 陈碧华, 李擎, 等. 分级诊疗背景下构建"心脏康复在社区"全科诊疗路径的实施对策[J]. 中华全科医学, 2021, 19(11): 1888-1892. doi: 10.16766/j.cnki.issn.1674-4152.002193WANG Q Q, CHEN B H, LI Q, et al. Implementation strategies for constructing a clinical path of cardiac rehabilitation in the community for community general practice care under hierarchical medical system[J]. Chinese Journal of General Practice, 2021, 19(11): 1888-1892. doi: 10.16766/j.cnki.issn.1674-4152.002193
|
[3] |
LOLLEY R, FORMAN D E. Cardiac rehabilitation and survival for ischemic heart disease[J]. Curr Cardiol Rep, 2021, 23(12): 184. doi: 10.1007/s11886-021-01616-x
|
[4] |
SALZWEDEL A, JENSEN K, RAUCH B, et al. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-Ⅱ)[J]. Eur J Prev Cardiol, 2020, 27(16): 1756-1774. doi: 10.1177/2047487320905719
|
[5] |
VILELA E M, LADEIRAS-LOPES R, JOAO A, et al. Current role and future perspectives of cardiac rehabilitation in coronary heart disease[J]. World J Cardiol, 2021, 13(12): 695-709. doi: 10.4330/wjc.v13.i12.695
|
[6] |
GONÇALVES C, RAIMUNDO A, ABREU A, et al. Exercise intensity in patients with cardiovascular diseases: systematic review with meta-analysis[J]. Int J Environ Res Public Health, 2021, 18(7): 3574. doi: 10.3390/ijerph18073574
|
[7] |
HANSEN D, ABREU A, AMBROSETTI M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology[J]. Eur J Prev Cardiol, 2022, 29(1): 230-245. doi: 10.1093/eurjpc/zwab007
|
[8] |
MEZZANI A, HAMM L F, JONES A M, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation[J]. Eur J Prev Cardiol, 2013, 20(3): 442-467. doi: 10.1177/2047487312460484
|
[9] |
AMORIM H, CADILHA R, PARADA F, et al. Progression of aerobic exercise intensity in a cardiac rehabilitation program[J]. Rev Port Cardiol (Engl Ed), 2019, 38(4): 281-286. doi: 10.1016/j.repc.2018.07.009
|
[10] |
PYMER S, NICHOLS S, PROSSER J, et al. Does exercise prescription based on estimated heart rate training zones exceed the ventilatory anaerobic threshold in patients with coronary heart disease undergoing usual-care cardiovascular rehabilitation? A United Kingdom perspective[J]. Eur J Prev Cardiol, 2020, 27(6): 579-589. doi: 10.1177/2047487319852711
|
[11] |
SEMPER H, KÜHNELT P, SEIPP P. Cardiopulmonary exercise testing-step by step[J]. Dtsch Med Wochenschr, 2019, 144(1): 39-45. doi: 10.1055/a-0600-9233
|
[12] |
MARCADET D M. Exercise testing: new guidelines[J]. Presse Med, 2019, 48(12): 1387-1392. doi: 10.1016/j.lpm.2019.09.011
|
[13] |
AMBROSETTI M, ABREU A, CORRÀ U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the european association of preventive cardiology[J]. Eur J Prev Cardiol, 2021, 28(5): 460-495. doi: 10.1177/2047487320913379
|
[14] |
TAYLOR J L, BONIKOWSKE A R, OLSON T P. Optimizing outcomes in cardiac rehabilitation: the importance of exercise intensity[J]. Front Cardiovasc Med, 2021, 8: 734278. DOI: 10.3389/fcvm.2021.734278.
|
[15] |
《药学与临床研究》编辑部. 如何正确运用组内相关系数进行一致性检验: 药物研究中的统计学(一)[J]. 药学与临床研究, 2018, 26(1): 78.Pharmaceutical and Clinical Research Editorial Department. How to correctly use intra-group correlation coefficient for consistency test-Statistics in drug research[J]. Pharmaceutical and Clinical Research, 2018, 26(1): 78.
|
[16] |
CHEN T, ZHU H, SU Q. Effectiveness and safety of four aerobic exercise intensity prescription techniques in rehabilitation training for patients with coronary heart disease[J]. Cardiol Res Pract, 2022, 2022: 1647809. DOI: 10.1155/2022/1647809.
|
[17] |
DÍAZ-BUSCHMANN I, JAUREGUIZAR K V, CALERO M J, et al. Programming exercise intensity in patients on beta-blocker treatment: the importance of choosing an appropriate method[J]. Eur J Prev Cardiol, 2014, 21(12): 1474-1480. doi: 10.1177/2047487313500214
|
[18] |
HANSEN D, BONNÉ K, ALDERS T, et al. Exercise training intensity determination in cardiovascular rehabilitation: should the guidelines be reconsidered?[J]. Eur J Prev Cardiol, 2019, 26(18): 1921-1928. doi: 10.1177/2047487319859450
|
[19] |
ZANETTINI R, CENTELEGHE P, RATTI F, et al. Training prescription in patients on beta-blockers: percentage peak exercise methods or self-regulation?[J]. Eur J Prev Cardiol, 2012, 19(2): 205-212. doi: 10.1177/1741826711398823
|
[20] |
DADOVA K, SLABY K, RADVANSKY J, et al. Exercise prescription in cardiac patients treated with metoprolol-should the time of day for stress tests and training coincide?[J]. Eur J Prev Cardiol, 2018, 25(10): 1026-1027. doi: 10.1177/2047487318771776
|